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c-MycThe human DEAD/H-box RNA helicase gene DDX6 is a target of the t(11;14)(q23;q32) chromosomal
translocation observed in human B-cell lymphoma, and the overexpression of its protein has been shown to
cause malignant transformation. DDX6 has a variety of functions such as translation initiation, pre-mRNA
splicing, ribosome assembly, and more. However, details of the regulatory mechanism of DDX6 and functions
of DDX6 in cancer cells are largely unknown. On the other hand, the Warburg effect is a well-known feature of
cancer cells. Pyruvate kinase in muscle (PKM), which is a rate-limiting glycolytic enzyme, has 2 isoforms,
PKM1 and PKM2. It has been frequently reported that PKM2 is a tumor-speciﬁc isoform and promotes the
Warburg effect. However, the functions of the PKM1 gene have been hardly mentioned. Here, we showed that
DDX6 was overexpressed in colorectal cancer specimens and regulated by microRNA (miR)-124 in colon cancer
cells. Also, a DDX6/c-Myc/PTB1 positive feedback circuit regulated by miR-124 was shown to be established and
to contribute to maintenance of the Warburg effect. Moreover, we showed that knockdown of DDX6 induced
mainly apoptosis through an imbalance of PKM gene expression, especially causing down-regulation of PKM1
in colon cancer cells. These results suggest that miR-124 is a ﬁne tuner of the Warburg effect and that DDX6 is
one of the key molecules in Warburg effect-related miR-124 targeting various genes.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The human DEAD/H-box RNA helicase gene DDX6 (also termed
RCK/p54) was previously identiﬁed through chromosomal breakpoint
studies on a t(11;14)(q23;q32) translocation in a B-cell lymphoma
cell line, RC-K8 [1–3]. Previously, we reported that the oncogenic
RNA helicase DDX6 is highly overexpressed in most malignant cell
lines and clinical colorectal tumors [4,5]. Also, we showed that DDX6
expression is linked to the regulation of cell growth and differentiation
of cancer cells through internal ribosomal entry site (IRES)-dependentynthetase; CPT1, carnitine
se 6; eIF4E, eukaryotic trans-
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uchi).translation of c-Myc [6–8]. Furthermore, DDX6 protein interacts with
the 5-cap structure-binding protein eIF4E,which is a rate-limiting factor
in the initiation of translation and acts as a translational regulator [6,7].
Recently, we found that DDX6negatively controls non-codingRNA gene
(NCR) 143/145 RNA stability in P-bodies and regulates miR-143/145
expression post-transcriptionally in cancer cells [9]. However, much is
still largely unknown about the functions of DDX6 in cancer cell growth.
MiRNAs are single-stranded non-coding small RNAs that repress
translation or induce degradation of target mRNAs through binding to
speciﬁc complementary sites within the 3′ untranslated region (3′UTR)
of mRNAs [10]. A great deal of evidence indicates that dysregulation of
miRNA expression contributes to the development of various human can-
cers, including colorectal cancer (CRC) [11,12]. Therefore, we investigated
which miRNAs targeted DDX6 and ﬁnally focused on miR-124.
MiR-124 is known as a brain-enriched miRNA and related with
physiological neural development [13,14]. Also, miR-124 play a
tumor-suppressor, especially against brain tumors [15] and various
cancers, including CRC [16,17]. Previously, we found that miR-124
targets polypyrimidine tract-binding protein 1 (PTB1, also known
as hnRNPI or PTBP1) and modulates cancer energy metabolism in
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(PKM) isoforms, which are rate-limiting glycolytic enzymes [17,18].
PKM has 2 isoforms, PKM1 and PKM2, which are produced by alter-
native splicing of transcripts in the PKM gene. PKM1 contains exon 9
and lacks exon 10, whereas PKM2 contains exon 10 and lacks exon 9
[19]. It has been frequently reported that PKM2 is exclusively expressed
in embryonic, proliferating, and cancer cells, and promotes theWarburg
effect [20,21]. On the other hand, itwas previously thought that PKM1 is
expressed in normal differentiated tissues and promotes oxidative
phosphorylation [22]. However, the functions of PKM1 hardly have
been elucidated yet.
In the current study, we sought to clarify the biological signiﬁcance
of DDX6 from the view point of the Warburg effect. We concluded
that DDX6 was partly regulated by miR-124. In addition, DDX6/c-Myc/
PTB1 was shown to constitute a positive feedback circuit regulated by
miR-124, which affects the Warburg effect. Moreover, we propose that
PKM1 played essential roles in the growth of cancer cells, as revealed
by the down-regulation of PKM1 by siR-DDX6.
2. Materials and methods
2.1. Patients and samples
The study was reviewed and approved by the institutional review
board of Gifu University Hospital (Gifu, Gifu, Japan) in accordance
with the Declaration of Helsinki. All patients were informed of the
investigational nature of the study and provided written informed con-
sent before enrollment in the study. All human samples were obtained
from patients who had undergone surgery for resection during 2014.
Twenty patients with previously untreated (or recently diagnosed)
colorectal cancer were selected. The characteristic of these patients are
shown in Table 1. Under a pathologist's supervision, all tissue samples
pairs were collected from surgically resected tissues, with these paired
samples being from the primary tumor and its adjacent non-tumor
mucosal tissue in the same patient.Table 1
Clinicopathological features in colorectal cancer.
Case Age Sexa Siteb Sizec Depthd Stagee DDX6f miR-124g
1 60 M R 52 × 68 SS C + D
2 62 M S 55 × 40 SS D + D
3 38 F R 50 × 95 MP A + D
4 52 M S 20 × 25 MP A + ND
5 67 M S 55 × 50 MP A + D
6 56 F S 27 × 24 SS C + D
7 59 F S 60 × 50 SE D + D
8 42 M R 30 × 20 SS B + D
9 53 F F 45 × 40 SS B + D
10 72 F A 35 × 32 SS B + D
11 81 M R 50 × 40 MP C + D
12 49 M R 50 × 40 SS B + D
13 68 F R 35 × 35 SS B + D
14 62 M R 39 × 38 MP A + D
15 82 F A 33 × 26 MP A − D
16 64 M R 28 × 22 MP A − D
17 73 M R 40 × 40 MP A − D
18 78 F C 21 × 25 SS B − ND
19 41 M R 70 × 45 SS B − ND
20 73 F T 55 × 25 SS D − ND
a M, male; F, female.
b Location of tumor; C, cecum; A, ascending colon; T, transverse colon; S, sigmoid colon;
R, rectum.
c Diameter in mm.
d MP, Mucosa propria; SS, Subserosa; SE, Serosa exposure; SI, Serosa invasion.
e Dukes' system.
f +, overexpression;−, no overexpression.
g D, down-regulation of miR-124 relative ratio (tumor tissue/normal adjacent
tissue b0.67).
ND, no down-regulation of miR-124 relative ratio (tumor tissue/normal adjacent
tissue ≧0.67).2.2. Cell culture and cell viability
All cell lines were obtained from JCRB (Japanese Collection of
Research Bioresources) Cell Bank. The medium used for the cultures
was RPMI-1640. The details of the cell culture method were described
in our previous reports [17,18]. The number of viable cells was
determined by performing the trypan-blue dye-exclusion test.
2.3. Transfection experiments
All cells were seeded in 6-well plates at a concentration of 0.5 × 105
per well (10–30% conﬂuence) on the day before the transfection. The
mature type of miR-124 (mirVana™ miRNA mimic; Ambion, Foster
City, CA, USA), antagomiR-124 (mirVana™miRNA inhibitor; Ambion)
and siRNAs for DDX6, PTB1, PKM1, PKM2, and c-Myc (Invitrogen
Carlsbad, CA) were used for the transfection of the cells, which was
achieved by using cationic liposomes, Lipofectamine™ RNAiMAX
(Invitrogen), according to the manufacturer's Lipofection protocol.
The nonspeciﬁc control miRNA (HSS, Hokkaido, Japan) sequence
was 5′-GUAGGAGUAGUGAAAGGCC-3′, which was used as a control
for nonspeciﬁc effects [23]. The sequence of the mature type of
miR-124 used in this study was 5′-UAAGGCACGCGGUGAAUGCC-3′;
that of siR-DDX6, 5′-GGAUAUUAUUCUCACGCUACCUAAA-3; that of
siR-PTB1, 5′-AUCUCUGGUCUGCUAAGGUCACUUC-3′; that of siR-c-
Myc, 5′-UUUGUGUUUCAACUGUUCUCGUCGU-3′; that of siR-PKM1,
5′-AAGUUCUUCAAACAGCUUGCGGUGG-3; and that of siR-PKM2,
5′-CAGACUUGGUGAGGACGAUUAUGGC-3′. The effects manifested
by the introduction of miRs and siRNAs into the cells were assessed
at 48 or 72 h after the transfection.
2.4. Western blotting
Whole cells were homogenized in chilled lysis buffer comprising
10 mM Tris–HCl (pH 7.4), 1% NP-40, 0.1% deoxycholic acid, 0.1%
SDS, 150 mM NaCl, 1 mM EDTA, and 1% Protease Inhibitor Cocktail
(Sigma-Aldrich Co.) and stood for 20 min on ice. After centrifugation
at 13,000 rpm for 20 min at 4 °C, the supernatants were collected as
whole-cell protein samples. Protein contents were measured with a
DC Protein assay kit (Biorad, Hercules, CA, USA). Ten micrograms
of lysate protein was separated by SDS-PAGE using 10.0 or 12.5%
polyacrylamide gels, and electroblotted onto a PVDF membrane
(PerkinElmer Life Sciences, Inc., Boston, MA, USA). After blockage
of nonspeciﬁc binding sites for 1 h with 5% nonfat milk in PBS con-
taining 0.1% Tween 20 (TBS-T), the membrane was incubated over-
night at 4 °C with primary antibodies. The next day, the membrane
was then washed 3 times with TBS-T, incubated further with second-
ary antibodies at room temperature for 1 h, and then washed 3 times
with TBS-T. The immunoblots were visualized by use of Amersham
ECL Plus Western Blotting Detection Reagents (GE Healthcare,
Buckinghamshire, UK). Primary antibodies used were as follows:
anti-PTB1, -PARP, -LC3B, -c-Myc, -ACSL1, -CPT1A (Cell Signaling
Technology, Inc., Danvers, MA, USA); anti-CPT1C (Santa Cruz
Biotechnology, CA, USA); anti-PKM1 and -PKM2 (Novus Biologicals,
USA); anti-caspase 9 (MBL, Nagoya Japan); anti-DDX6 [6], and anti-β-
actin antibody (Sigma-Aldrich Co.). HRP-conjugated goat anti-rabbit
and horse anti-mouse IgG (Cell Signaling Technology) were used as
secondary antibodies. β-actin was used as an internal control.
2.5. Real-time reverse transcription-PCR
Total RNA was isolated from cultured cells or tumor tissues by
using a Nucleo Spin microRNA isolation kit (TaKaRa, Otsu, Japan).
To determine the expression levels of miR-124, we conducted quantita-
tive RT-PCR (qRT-PCR) by using TaqMan MicroRNA Assays (Applied
Biosystems) and THUNDERBIRD Probe qPCR Mix (TOYOBO Co., LTD.,
Osaka Japan) according to the manufacturer's protocol. RNU6B was
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DDX6 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNAs, total RNA was reverse-transcribed with a PrimeScript® RT re-
agent Kit (TaKaRa). Real-time PCR was then performed with primers
speciﬁc for them by using THUNDERBIRD SYBR qPCR Mix (TOYOBO).
The primers for DDX6 and GAPDH were the following: DDX6-sense,
5′-GGC TGG GAA AAG CCA TCT-3′, and DDX6-antisense, 5′-ACC TGA
TCT TCC AAT ACG-3′; GAPDH-sense, 5′-CCA CCC ATG GCA AAT TCC
ATG GCA-3′, and GAPDH-antisense, 5′-TCT AGA CGG CAG GTC AGG
TCC ACC-3′. GAPDH was used as an internal control. The relative
expression levels were calculated by the ΔΔCt method.
2.6. Luciferase reporter assay
Searching the Target Scan 6.2 database (http://www.targetscan.org/)
toﬁnd algorithm-based binding sites ofmiR-124,we found the predicted
binding sites to be at position 455–462 in the 3′UTR of DDX6 mRNA.
The region 2270–2366 of DDX6, containing the putative binding se-
quence of miR-124, was inserted into a pMIR-REPORT™ Luciferase
miRNA Expression Reporter Vector (Applied Biosystems) according the
manufacturer's protocol. Moreover, we made another pMIR construct
encompassing a mutated seed sequence for miR-124 (Wild type, GTGC
CTT; mutant, GTATTTT) by using a PrimeSTAR® Mutagenesis Basal Kit
(TaKaRa). The mutation of the vector was conﬁrmed by sequence
analysis. pRL-TK Renilla Luciferase Reporter vector (Promega, Madison
WI, USA) was used as an internal control vector. DLD-1 were seeded
into 96-well plates at a concentration of 0.5 × 104 per well on the
day before the transfection. The cells were co-transfected with either
reporter vector (0.01 μg/well each) and 20 nM miR-124 or nonspeciﬁc
non-coding siRNA (Dharmacon, Tokyo, Japan), which co-transfection
was achieved by using Lipofectamine™ RNAiMAX. Luciferase activities
were measured at 24 h after co-transfection by using a Dual-Glo
Luciferase Assay System (Promega) according to the manufacturer's
protocol. Luciferase activities were reported as the ﬁreﬂy luciferase/
Renilla luciferase ratio.
2.7. Electron microscopic study
DLD-1 cells treated or not with miR-124 (40 nM) or siR-DDX6
(10 nM). The details of the method were described in our previous
reports [17,24].
2.8. Hoechst 33342 staining
DLD-1 cells were collected at 48 or 72 h after the transfection. The
cellswere stainedwithHoechst 33342 (5 μg/ml) at 37 °C for 1 h,washed
once with phosphate-buffered saline, resuspended, pipetted dropwise
onto a glass slide, and examined by ﬂuorescence microscopy using an
Olympus microscope (Tokyo, Japan) equipped with an epi-
illuminator and appropriate ﬁlters. The cells with condensed and/
or fragmented nuclei stained with Hoechst 33342 were assessed to
be apoptotic, and the number of apoptotic cells among 200 cells
was counted.
2.9. Lactate assay
DLD-1 cells were collected at 48 h after the transfection. Lactate was
measured with an L-Lactate Assay kit according to the manufacturer's
instructions (Cayman Chemical Company, Michigan, USA). Lactate
production was normalized to the number of cells.
2.10. Statistics
Each examination was performed in triplicate. In experiments
on clinical samples, we calculated the relative miR-124 ratio
of tumor/adjacent normal tissues. We deﬁned the expressionlevels N1.5 as up-regulation and those b0.67 as down-regulation,
which fold changes were obtained from the results of linear discrimi-
nant analysis of the miRNA expression patterns from many of our pre-
vious reports [25,26]. Statistical signiﬁcances of differences were
evaluated by performing the two-sided Student's t-test. The values
were presented as the mean ± standard deviation. A P value b0.05
was considered to be statistically signiﬁcant.
3. Results
3.1. Overexpression of DDX6 and down-regulation of miR-124 in clinical
colorectal tumors
Previously,we found that DDX6 is highly overexpressed in colorectal
tumor [4,5]. Again, we conﬁrmed the overexpression of DDX6 in clinical
colorectal tumor samples by performing Western blot analysis. As a
result, 14 out of the 20 cases examined showed up-regulated DDX6
(Fig. 1A and Table 1). In order to clarify the role of miRNAs in the
overexpression of DDX6, we searched the database of Target Scan 6.2
(http://www.targetscan.org/), with the results indicating that several
miRNAs targeted DDX6. Among them, only miR-124 had a higher
probability of preferential targeting of the conserved sites in the 3′UTR
of DDX6. In addition, the DDX6 expression level after the transfection
of DLD-1 cells with miR-124 was more down-regulated than that
after transfection with other miRs that targeted DDX6, such as miR-19
(Supplementary Fig. S1). Based on these ﬁndings, we focused on the
relationship between DDX6 and miR-124 as a negative regulator of it.
As to the expression level of miR-124 in the clinical samples, 16 of the
20 cases showed a signiﬁcant down-regulation of miR-124 (Fig. 1B).
Moreover, 13 of the 14 cases with overexpressed DDX6 also showed a
signiﬁcantly low expression of miR-124 (Fig. 1A, B and Table 1). These
ﬁndings implied that the overexpression of DDX6 in colorectal tumor
was regulated at least in part by miR-124.
3.2. DDX6 is a direct target of miR-124 in colon cancer cells
To further clarify the relationship between DDX6 and miR-124,
we ﬁrstly examined the mRNA and protein expression of DDX6 after
we had transfected human colon cancer DLD-1 and WiDr cells with
miR-124. As shown in Fig. 1C and D, the mRNA and protein expression
of DDX6 were remarkably down-regulated in both cells. Also, we
found that the ectopic expression of miR-124 signiﬁcantly down-
regulated DDX6 in other human colon cancer COLO201, too. However,
we couldn't ﬁnd the same effect in human colon cancer SW480 cells
(Supplementary Fig. S2). Secondly, we performed a luciferase activity
assay for DDX6 and found that the activity of wild-type pMIR-DDX6
was signiﬁcantly inhibited after the introduction of miR-124 into
DLD-1 cells. On the other hand, mutation of the DDX6 3′-UTR-binding
site markedly abolished this ability of miR-124 (Fig. 1E). Thirdly, treat-
ment with antagomir-124 reversed the growth inhibition elicited by
miR-124 and the increased expression level of DDX6 in both cells
(Fig. 1F). These ﬁndings altogether suggested that miR-124 targeted
DDX6, thus contributing to the down-regulation of DDX6 at the
translational level in colon cancer cells. Actually, the down-regulated
miR-124 could cause the overexpression of DDX6 at least in part in
colon cancer cells.
3.3. Knockdown of DDX6 induces apoptosis in colon cancer cells
To validate the function of DDX6, we examined the effects of gene
silencing of DDX6 in human colon cancer DLD-1 and WiDr cells. As
shown in Fig. 2A, this gene silencing induced a signiﬁcant growth
inhibition in both cells. Western blotting analysis clearly showed the
cleaved form of PARP-1 and the active forms of caspase 9; whereas a
signiﬁcant transition of LC3I to LC3II was not found in either cell type
(Fig. 2B). Moreover, Hoechst 33342 nuclear staining indicated a typical
Fig. 1. (A, B) Overexpression of DDX6 and down-regulation of miR-124 in clinical colorectal tumors. (A) The protein expression of DDX6 in the 20 clinical samples. Densitometric values
are shown for DDX6 in each sample (B). Expression of miR-124 in 20 colorectal tumor clinical samples. The value of each sample was expressed as the ratio of the expression in tumor
sample to that in normal adjacent tumor sample. The lower cases (ratio under 0.67) and the higher cases (ratio above 1.5) are signiﬁcant. Dotted line in the graph shows the ratio of 0.67.
(C)–(F)MiR-124 targeted DDX6 and contributed to the expression of DDX6 in colon cancer cells. ThemRNA (C) and protein expression (D) of DDX6 in DLD-1 andWiDr cells at 72 h after
the transfectionwithmiR-124 (20, 40 nM) is shown.Densitometric values are shown for DDX6 inWiDr cells after the transfectionwithmiR-124. (E) Luciferase activities after co-transfection
with control ormiR-124 andwild-type ormutant-typepMIR vectors having the predictivemiR-124 binding site in the 3′UTR of DDX6 are also given. Theupper panel shows the region of the
3′-UTR of human DDX6mRNA complementary to the mature miR-124. The box indicates the predicted binding sites for miR-124. (F) Also, the effect of combined treatment of DLD-1 cells
with antagomiR-124 and miR-124 is indicated. DLD-1 cells were transfected with non-speciﬁc control, miR-124 (20 nM), miR-124 (20 nM) + antagomiR-124 (10 nM) or miR-124
(20 nM) + antagomiR-124 (20 nM). WiDr cells were transfected with non-speciﬁc control, miR-124 (40 nM), miR-124 (40 nM) + antagomiR-124 (20 nM) or miR-124
(40 nM) + antagomiR-124 (40 nM). Left panel: viable cell rate; Right panel: the expression level of DDX6 was assessed at 72 h after the transfection. Densitometric values
are shown for DDX6. Results are presented as mean ± SD; *P b 0.05 **P b 0.01; ***P b 0.001. N.S., not statistically signiﬁcant.
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fragmentation in the siR-DDX6-treated DLD-1 cells (Fig. 2C). These
ﬁndings suggested that knockdown of DDX6 induced apoptosis in
colon cancer cells.
3.4. MiR-124 regulates the Warburg effect through the PTB1/PKM axis by
targeting PTB1
Next, we examined the effects of ectopic expression of miR-124 in
colon cancer cells. As a result, the growth of either cell line was sig-
niﬁcantly inhibited, even at 20 nM (Fig. 3A). Previously, we found
that miR-124 targets PTB1, which is a splicer of the PKM gene and
modulates theWarburg effect through the switching of PKM isoform
expression from PKM2, which is dominant in proliferating cells, toPKM1 [18]. The ectopic expression of miR-124 or gene silencing of
PTB1 induced the switching of PKM isoform expression from PKM2
to PKM1 in both cells, as reported before (Fig. 3B and C). These
results indicated that the miR-124/PTB1/PKM axis contributed to
the Warburg effect. Furthermore, Western blot analysis indicated
that the cleaved form of PARP-1 and the active forms of caspase-9
were remarkably evident (Fig. 3D), and Hoechst 33342 nuclear
staining revealed the typical apoptotic appearance (Fig. 3E), in
the miR-124-treated DLD-1 cells. Also, the ectopic expression of
miR-124 induced a signiﬁcant transition of LC3I to LC3II in both
kinds of cells (Fig. 3D). Moreover, morphologically, we compared
the electron microscopic ﬁndings made after transfection with
miR-124 or siR-DDX6. The results showed that the ectopic expres-
sion of miR-124 induced apoptosis combined with autophagy;
Fig. 2.Knockdown of DDX6 induced mainly apoptosis in colon cancer cells. (A) Effects of DDX6 knockdown on cell growth of colon cancer cells and (B) on the protein expression
of apoptosis and autophagy-related genes when knockdown of DDX6 in colon cancer cells was performed. We transfected DLD-1 and WiDr cells with siR-DDX6 at a
concentration of 5 or 10 nM. The effects were evaluated at 72 h after the transfection. The active form of caspase 9 in WiDr cells is indicated by the black arrow. (C) Hoechst
33342 staining at 72 h after knockdown of DDX6 in DLD-1 cells at a siR-DDX6 concentration of 5 nM. Apoptotic cells are indicated by the white arrows. Results are presented
as the mean ± SD;**P b 0.01; ***P b 0.001.
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were consistent with those obtained from the biological chemical
analyses. This phenotypic difference, especially in silencing DDX6,
may reﬂect the differences in the expression proﬁle of PKM isoforms.
3.5. DDX6/c-Myc/PTB1 constitutes a circuit regulated by miR-124 and
affects the Warburg effect
C-Myc is known as one of the molecules strongly contributing to
glycolysis in cancer cells [27]; and it up-regulates transcription of
PTB1, ensuring a high PKM2/PKM1 ratio [28]. Previously, we found
that DDX6 exhibits RNA unwinding activity toward c-Myc RNAs [29]
and promotes translation of c-Myc mRNA by unfolding the IRES struc-
ture of its 5′UTR [5,7,8]. Based on these ﬁndings, we tried to clarify the
mechanism by which DDX6 contributed to the Warburg effect through
the regulation of c-Myc and PTB1. Firstly, we performed the knockdown
of c-Myc in both cells. Expectedly, gene silencing of c-Myc up-regulated
the PKM1/PKM2 ratio through the down-regulation of PTB1 as seen in
ectopic expression miR-124 or gene silencing of PTB1 (Fig. 4A). Also,
gene silencing of DDX6 down-regulated PTB1 through the repression
of c-Myc in both cells (Fig. 4B). Furthermore, the ectopic expression of
miR-124 down-regulated c-Myc in both cells (Fig. 4C). Therefore, we fo-
cused on the expression of PKM isoforms and production of lactate,
which is the ﬁnal product of the glycolysis pathway, after the gene
silencing of DDX6. As a result, the knockdown of DDX6 decreased the
expression of PKM2 and lactate production (Fig. 4B and D). Of course,
the ectopic expression of miR-124 decreased lactate production
(Fig. 4D). These ﬁndings suggested that DDX6 contributed to the
Warburg effect through the regulation of the c-Myc/PTB1/PKM2
pathway and that miR-124 regulated this pathway. Unexpectedly,
gene silencing of DDX6 down-regulated PKM1 expression in both
cells. In addition, the expression levels of miR-124 were signiﬁcantly
up-regulated and the protein expression of DDX6 and c-Myc weresigniﬁcantly down-regulated after the transfection with siR-PTB1
(Fig. 4E and F). These ﬁndings taken together suggested that DDX6,
c-Myc, and PTB1 formed a positive feedback-like circuit and that
miR-124 regulated this circuit through the modulation of DDX6
and PTB1 expression.
3.6. Knockdown of DDX6 induces apoptosis through the down-regulation of
PKM1 in colon cancer cells
Based on the results shown in Fig. 4B, we hypothesized that
the down-regulation of PKM1 was likely related to the induction
of apoptosis caused by the knockdown of DDX6. Therefore, we
examined the effects of gene silencing PKM1 on the growth of
both kinds of cells. As a result, the gene silencing of PKM1 induced
a signiﬁcant growth inhibition in both cell lines (Fig. 5A). In addi-
tion, Western blot analysis indicated that the levels of the cleaved
form of PARP-1 and the active form of caspase-9 were remarkably
elevated after the transfection of either cell type with siR-PKM1,
even when used at 2 nM; whereas the transition LC3I to LC3II
was not seen (Fig. 5B), as was also the case for siR-DDX6 (Fig. 2B).
Moreover, Hoechst 33342 nuclear staining indicated typical apo-
ptotic ﬁndings such as condensed chromatin and nuclear frag-
mentation in the siR-PKM1-treated DLD-1 cells (Fig. 5C). All of
these ﬁndings taken together suggested that PKM1 was closely
associated with the induction of apoptosis, which was also ob-
served through the down-regulation of PKM1 after the transfection
with siR-DDX6.
3.7. PKM1 is one of the molecules responsible for the induction of apoptosis
by acting through the miR-124/PTB1/PKM axis
Finally, to further validate the functions and importance of PKM1,
which was down-regulated only in DDX6-silenced cells, resulting
Fig. 3.MiR-124 regulated PTB1/PKM axis and induced apoptosis and autophagy in colon cancer cells. (A) Effects of ectopic expression of miR-124 on cell growth of colon cancer cells. (B and C)
The protein expression ofWarburg effect-associated genes after the transfection of colon cancer cellswithmiR-124 (B) or siR-PTB1 (C). The concentration ofmiR-124 usedwas 20 or 40 nM. That
of siR-PTB1 usedwas 5 or 10 nM. The effectswere evaluated at 72 h after the transfection. (D) Protein expression of apoptosis- and autophagy-related geneswhen ectopic expression ofmiR-124
in colon cancer cells was performed. The concentration of miR-124 used was 20 or 40 nM. The effects were evaluated at 72 h after the transfection. The active form of caspase 9 inWiDr cells is
indicated by the black arrow. (E) Results of Hoechst 33342 staining at 72 h after treatment with miR-124 in DLD-1 cells at a miR-124 concentration of 20 nM. Apoptotic cells are indicated by
the white arrows. (F) Morphological study by using electron microscopy. DLD-1 cells were treated with control miRNA, miR-124 (40 nM) or siR-DDX6 (10 nM) for 72 h. N: fragmented nuclei,
V: vacuole. Results are presented as the mean ± SD; ***P b 0.001.
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Fig. 4. DDX6, c-Myc, and PTB1 constituted a circuit regulated by miR-124 and affected the Warburg effect. The protein expression of Warburg effect-associated genes after the transfection of
colon cancer cellswith siR-c-Myc (A) or siR-DDX6 (B) is shown. The expressionof these proteinswas assessed at 72 h after the transfection. The concentrations of siR-c-Myc and siR-DDX6were
5 and 10 nM, respectively. (C) The protein expression of c-Myc after the transfection of colon cancer cells with miR-124 is shown. The expression of these proteins was assessed at 72 h after
the transfection. The concentration of miR-124was 20 or 40 nM. (D) Lactate productionwasmeasured at 48 h after the transfection of DLD-1 cells withmiR-124 (20 nM) or siR-DDX6 (5 nM).
(E and F) The expression levels of miR-124 (E) and the protein expression of miR-124-related genes (F) after the transfection of colon cancer cells with siR-PTB1 are shown. The effects were
detected at 72 h after the transfection with siR-PTB1. The concentration of siR-PTB1 used was 5 or 10 nM. Results are presented as the mean ± SD; *P b 0.05;***P b 0.001.
1977K. Taniguchi et al. / Biochimica et Biophysica Acta 1852 (2015) 1971–1980in cancer cell death, we compared the effects of knockdown of PKM1,
PKM2 or both and made two interesting ﬁndings. Firstly, as shown in
Fig. 5D, the strength of growth inhibition after the transfection with
siR-PKM1 was almost the same as that with siR-PKM2, which is the
dominant isoform in cancer cells [18]. Secondly, the cleaved forms
of PARP-1 were observed only in the case of knockdown of PKM1
(siR-PKM1 or siR-PKM1 + PKM2) by Western blot analysis
(Fig. 5E). These ﬁndings suggested that PKM1 played important
roles in promoting cancer cell growth, comparable to those of
PKM2, which is dominant in the Warburg effect in cancer cells
(Fig. 6).4. Discussion
In the current study, we ﬁrstly demonstrated that the up-regulated
expression of DDX6 in colon cancer cells was partly associated with
the RNA-interference effect by miR-124 that targets PTB1 (Figs. 1, 4E
and F). Of course, we should consider other machineries of DDX6 over-
expression, too. For example, it has been reported that the miR-130
family regulates the hypoxia response signal through the targeting of
DDX6 [30].
Earlier, we proved that many kinds of miRs, such as miR-143
and -145, are down-regulated during colorectal tumor development
Fig. 5. PKM1 is one of the molecules responsible for cancer cell growth. (A) Effects of PKM1 knockdown with its siR on cell growth of colon cancer cells and (B) protein expression of ap-
optosis, autophagy, andWarburg effect-related genes when knockdown of PKM1 in colon cancer cells was performed. We transfected DLD-1 andWiDr cells with siR-PKM1 at a concen-
tration of 2 or 5 nM. The effects were evaluated at 48 h after the transfection. (C) Hoechst 33342 staining at 48 h after knockdown of PKM1 in DLD-1 cells at a siR-PKM1 concentration of
5 nM. Apoptotic cells are indicated by thewhite arrows. (D) Effects of knockdown of PKM1, PKM2 or PKM1+ PKM2 on cell growth in colon cancer cells and (E) the protein expression of
apoptosis andWarburg effect-related geneswhen knockdown of PKM1, PKM2 or PKM1+PKM2 in colon cancer cells was done.We transfectedDLD-1 andWiDr cells with siR-PKM1, siR-
PKM2 or siR-PKM1 + siR-PKM2 at a concentration of 5, 5 or 2.5 + 2.5 nM. The effects were evaluated at 48 h after the transfection. Results presented as the mean ± SD; *P b 0.05;
**P b 0.01; ***P b 0.001. N.S., not statistically signiﬁcant.
1978 K. Taniguchi et al. / Biochimica et Biophysica Acta 1852 (2015) 1971–1980[31,32]; and recently, we reported that the expression of such onco-
related miRNAs was closely associated with the morphological ap-
pearance of colorectal tumors [26]. Therefore, we consider that the
down-regulation and loss of functions of these anti-oncomiRs caused
gain of functions of targeting oncogenes during carcinogenesis. It has
been reported that dysregulation of anti-oncomiRs such as miR-124
is caused by epigenetic abnormalities such as methylation [11,33].
However, the mechanisms and effects of such dysregulation are
still largely unknown.There are some mechanisms known to be involved in the growth
inhibition induced by knockdown of DDX6. Previously, we found
that siR-DDX6 induced cell-cycle arrest at the S phase in HeLa cells
[6]. In addition, we found that DDX6 protein interacts with the
5′-cap structure-binding protein eIF4E, which is well known as a
rate-limiting factor in the initiation of translation. Therefore, many
genes related to cancer cell growth such as those of the Wnt signal-
ing pathway, as well as phosphorylation of Akt, are down-regulated
by knockdown of DDX6 [6,34]. One of the interesting ﬁndings made
Fig. 6. Schematic diagram of DDX6/c-Myc/PTB1 circuit regulated by miR-124. DDX6 is highly overexpressed in colorectal tumors, and miR-124 contributes to that expression. MiR-124
directly targets DDX6 in colon cancer cells. DDX6 regulates the expression level of c-Myc and c-Myc regulated the expression of PTB1 directly. Also, miR-124 regulates the expression
of c-Myc indirectly. Furthermore, siR-PTB1 up-regulated the expression level ofmiR-124 and down-regulated the expression of DDX6 and c-Myc. Therefore, DDX6/c-Myc/PTB1 constitutes
a circuit regulated by miR-124 and affects the Warburg effect. On the other hand, knockdown of DDX6 induced apoptosis through an imbalance of PKM expression, especially by
that caused by down-regulation of PKM1 in colon cancer cells. Knockdown of PKM1 induced typical apoptosis in colon cancer cells. PKM1 is one of the essential molecules in
cancer cell proliferation.
1979K. Taniguchi et al. / Biochimica et Biophysica Acta 1852 (2015) 1971–1980in this study was that knockdown of DDX6 down-regulated the ex-
pression of Warburg effect-related genes such as PTB1 and PKM2
and affected production of lactate, which is the ﬁnal product of the
glycolysis pathway (Fig. 4B and D). Previously, we found that DDX6
acts as a translational promoter of c-Myc mRNA [5,7,29]. Also,
c-Myc is well known as one of the molecules strongly contributing
to glycolysis in cancer cells [27,28]. Therefore we hypothesized that
knockdown of DDX6 affected the Warburg effect through down-
regulation of c-Myc. Based on this hypothesis, in this study, we
showed that DDX6, c-Myc, and PTB1 constitute a positive- feedback
network regulated by miR-124 (Figs. 4 and 6).
Next, we want to emphasize especially that our present study
revealed that PKM1 played an important role in cancer cell growth,
even though PKM1 was shown to be expressed in very low amount in
cancer cells. Previously, we found that the expression level of PKM1 is
much lower than that of PKM2 in all cancer cell lines and even in control
cell lines and in cells in primary culture tested [18]. It has been
well established that PKM2 has important functions in cancer cell
growth [20]. Recently, we reported that the PKM2/PKM1 ratio was
up-regulated during tumor development induced by down-regulation
of PTB1-associated miRs including miR-124 in colorectal tumor [18].
Also, it has been reported that PKM2 has various other functions in
cancer cells. For example, PKM2 regulates gene transcription by acting
as a protein kinase and directly phosphorylating STAT3 [35]. In addition,
nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
[36]. However, the functions of PKM1 have been hardly known until
now. In this study, we found this kinase to be one of the essential mol-
ecules in cancer cell growth, based on the results of PKM1 silencing
(Fig. 5). As stated above, PTB1 is regulated by c-Myc (Fig. 4A). Therefore,
at ﬁrst, we hypothesized that the knockdown of DDX6 induces
switching of PKM isoforms from PKM2 to PKM1 as seen in the transfec-
tion with miR-124, siR-PTB1 or -c-Myc (Figs. 3B, C and 4A). However,
PKM1 was down-regulated as well as PKM2 (Fig. 4C). To clarify
the mechanism of this result, we considered the possibility of other
gluconeogenesis such as β-oxidation. Therefore, we examined the
expression levels of several enzymes which are rate-limiting factors of
β-oxidation. The expression level of long-chain acyl-CoA synthetase
(ACSL1) was almost unchanged in siR-DDX6-treated cells. However,
the expression level of carnitine palmitoyltransferase-1A (CPT1A)
was up-regulated in siR-DDX6-treated DLD-1 cells and that ofcarnitine palmitoyltransferase-1C (CPT1C) was up-regulated in
both cells (Supplementary Fig. S3A). Furthermore, the sensitivity to
Hydrogen peroxide (H2O2) was signiﬁcantly increased in siR-
DDX6-treated cells (Supplementary Fig. S3B). Also, it has been re-
ported that fatty acid oxidation (FAO) cancels the accumulation of
Reactive Oxygen Species (ROS) in conditions of metabolic stress
through the generation of NADPH [37,38]. By considering these ﬁnd-
ings, it is possible that siR-DDX6-treated cells activate compensatory
FAO to produce energy for survival and avoid fatal situation caused
by accumulation of ROS through acceleration of TCA-cycle by up-
regulated PKM1. Of course, further investigation will be needed to
clarify the mechanism of down-regulation of PKM1 in siR-DDX6-
treated cells. On the other hand, the database Target Scan 6.2
shows that 3′UTR of PKM is targeted by only miR-122. We found
that the ectopic expression of miR-122 down-regulated both PKM1
and PKM2 in DLD-1 cells because the 3′UTR of PKM1 and PKM2 is
common in both. Also, the cleaved form of PARP-1 was signiﬁcantly
up-regulated after the treatment with miR-122 in DLD-1 cells (Sup-
plementary Fig. S4). We consider that these results support the no-
tion that down-regulation of PKM1 induced apoptosis. It is known
that PKM1 promotes oxidative phosphorylation [22]. In our results,
knockdown of PKM1 activated the intrinsic apoptosis pathway
(Fig. 5B and C). This ﬁnding may be evidence that PKM1 was closely
related to mitochondrial functions. To elucidate the molecular func-
tions of PKM1 in cancer cells, further study will be needed and is now
under way. These ﬁndings taken together suggest that the oncogene
RNA helicase DDX6 is extremely important not only to maintain
a stable onco-related gene expression, but also to maintain the
Warburg effect through the machineries of gene translation and
energy metabolism mediated by miR-124.5. Conclusions
The important ﬁnding in this study was that DDX6 affected the
Warburg effect through theDDX6/c-Myc/PTB1positive-feedback circuit
regulated partly by miR-124. Another important ﬁnding was that the
balance of PKM1/PKM2 was crucial to the growth of cancer cells.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.06.022.
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